What is end-stage kidney disease (ESKD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is ESKD?

ESKD (End-Stage Kidney Disease) is an outdated administrative term that should be avoided in clinical practice; the preferred term is "kidney failure," defined as GFR <15 mL/min per 1.73 m² or treatment with dialysis or transplantation. 1

Current Nomenclature Recommendation

The 2020 KDIGO consensus conference strongly recommended abandoning the term "end-stage" for several important reasons 1:

  • Not well-defined or consistently used except for administrative purposes (primarily U.S. Medicare billing)
  • Misleadingly implies imminent death when patients can survive for years with treatment
  • Creates stigma and psychological burden for patients
  • Excludes patients with the same severity who don't receive dialysis (by choice, lack of access, or lack of recognition)

What ESKD Actually Means

Administrative Definition

In the United States, ESRD (End-Stage Renal Disease) is a federal statute term that defines eligibility for Medicare benefits: "a medical condition in which a person's kidneys cease functioning on a permanent basis leading to the need for a regular course of long-term dialysis or a kidney transplant to maintain life" 2. This is a billing classification, not a clinical definition.

Clinical Reality

The term has been used inconsistently, ranging from:

  • A synonym for dialysis patients only
  • A descriptor for patients with kidney failure regardless of treatment status 1

Preferred Terminology: Kidney Failure

Use "kidney failure" instead, defined as 2:

  • GFR <15 mL/min per 1.73 m² (accompanied in most cases by uremic symptoms), OR
  • Need for kidney replacement therapy (dialysis or transplantation)

This definition is precise, clinically meaningful, and applies to all patients with this severity of disease regardless of treatment status.

Clinical Context

Kidney failure represents Stage 5 chronic kidney disease and affects approximately 0.1% of the U.S. adult population 2. Approximately 98% of patients with kidney failure in the United States begin dialysis when their GFR falls below 15 mL/min per 1.73 m² 2.

Key distinction: ESKD/ESRD is an administrative classification based on treatment receipt, while kidney failure is a clinical diagnosis based on kidney function level 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.